International Clinical Trial: Exploratory Study Protocol on the Efficacy and Safety of Telitacicept for Injection in Patients with Primary Sjogren's Syndrome Complicated by Hematologic Involvement

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118445) titled 'Exploratory Study Protocol on the Efficacy and Safety of Telitacicept for Injection in Patients with Primary Sjogren's Syndrome Complicated by Hematologic Involvement' on Feb. 5.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital, Sichuan University

Condition: Sjogren's Syndrome

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-03-01

Target Sample Size: Telitacicept treatment group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=287254

Published by HT Digital Content Services w...